Aehr Test Systems (AEHR)
Aehr Test Systems Heads Into A Critical Year
AEHR is a high-risk, high-reward binary play, with fiscal 2026 hugely important for the mid- to long-term investment case. The recent acquisition of Incal and AI processor exposure have repositioned Aehr from an 'EV loser' to a potential 'AI winner,' expanding its addressable market. Despite optimism, fundamentals remain weak: high valuation, margin pressure, and a history of failed growth spurts raise caution.
Here's Why Aehr Test Systems Stock Had a Wild Ride in the First Half of 2025
Shares in Aehr Test Systems (AEHR -3.26%) slumped by 22.2% in the first half of 2025, according to data provided by S&P Global Market Intelligence. That figure may surprise investors, not least because it's a long, long way from telling the whole story of a stock that declined 56% in the first three months of 2025 only to rise 77.4% in the last three months of the half-year.
Aehr Test Systems: From Transitional Year To A Multi-Year Growth Cycle
Despite weak Q4 FY 2025 earnings, Aehr Test Systems has diversified its revenue streams and reduced its reliance on the SiC segment substantially, a promising sign for future growth. AEHR secured a major hyperscaler as its first AI customer and is demonstrating its systems with 2 more potential customers. Silicon photonics could be a large market for AEHR thanks to its relationship with an OSAT, potentially expanding its market reach indirectly.
Aehr Systems: Unwarranted Reaction To Q4 Earnings Results, But Short Term Does Look Bad
Aehr Systems' Q4 results disappointed due to tariff uncertainty and sharp sales declines, especially in WaferPak, though packaged burn-in systems showed strength from AI demand. The company maintains a strong cash position with no debt, providing some cushion against ongoing volatility and negative sentiment in the market. Tariff risks and the end of US EV tax credits will likely prolong weakness in the EV segment, but AI-driven growth offers a promising offset.
Aehr Test Systems, Inc. (AEHR) Q4 2025 Earnings Call Transcript
Aehr Test Systems, Inc. (NASDAQ:AEHR ) Q4 2025 Earnings Conference Call July 8, 2025 5:00 PM ET Company Participants Chris P. Siu - CFO, Executive VP of Finance & Secretary Gayn Erickson - President, CEO & Director Conference Call Participants Christian David Schwab - Craig-Hallum Capital Group LLC, Research Division Jonathan Dorsheimer - William Blair & Company L.L.C.
Aehr Test Systems (AEHR) Surges 9.3%: Is This an Indication of Further Gains?
Aehr Test Systems (AEHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Navitas Jumped - And Why Aehr Will Soon Follow
Navitas Semiconductor surged from under $2 to over $8 per share in less than a month due to the adoption of Navitas' chips by Nvidia. This partnership with Nvidia significantly boosts Navitas' growth prospects and market credibility. This provides a critical new growth vector for power compound semiconductors, which will eventually flow through to Aehr.
Aehr Test Systems, Inc. (AEHR) Q3 2025 Earnings Call Transcript
Aehr Test Systems, Inc. (NASDAQ:AEHR ) Q3 2025 Earnings Conference Call April 8, 2025 5:00 PM ET Company Participants Jim Byers - PondelWilkinson, IR Gayn Erickson - President & CEO Chris Siu - CFO Conference Call Participants Tyler Burmeister - Craig-Hallum Capital Group Jed Dorsheimer - William Blair Larry Chlebina - Chlebina Capital Operator Greetings. Welcome to the Aehr Test Systems Fiscal 2025 Third Quarter Financial Results Call.
Aehr Test Systems (AEHR) Q3 Earnings and Revenues Top Estimates
Aehr Test Systems (AEHR) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.03 per share a year ago.
Aehr Test Systems: An Earnings Show-Me Story, Optimistic For A Turnaround
Aehr Test Systems has faced significant challenges, including weak silicon carbide sales and intense competition, but remains a buy due to low valuation and potential EPS growth. Despite a sharp underperformance since early 2024 and a disappointing Q2, AEHR is diversifying revenue streams and expanding into AI processors, which could drive future growth. Key risks include ongoing supply chain issues, competition, and uncertainties in the silicon carbide market, but recent positive economic data from China offers hope for a turnaround.
Here's Why Shares in Aehr Test Systems Fell This Week
Shares in semiconductor testing equipment company Aehr Test Systems (AEHR 4.81%) slumped by 8.6% in the week to Friday morning. The move came as the market digested the news of Chinese start-up DeepSeek's release of its updated artificial intelligence (AI) models.
Aehr Test Systems: Bull vs. Bear
Aehr Test Systems (AEHR -0.56%) is a provider of semiconductor testing equipment and other solutions and has exposure to growth trends, including artificial intelligence (AI) and EVs. Its products are highly regarded, and the company enjoys long-term growth catalysts.
